
880 Prostate cancer cell proliferation is strongly reduced by combination treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (‘Iressa’) and the anti -androgen bicalutamide (‘casodex’)
M. Bologna, A. Angelucci, C. Festuccia, G.L. Gravina, P. Muzi, C. VicentiniVolume:
1
Année:
2003
Langue:
english
DOI:
10.1016/s1359-6349(03)90906-2
Fichier:
PDF, 166 KB
english, 2003